oxaliplatin, capecitabine, bevacizumab

TERMINATED · PHASE2 · Colorectal Cancer, Neoplasm Metastasis

positive results from a larger study with same regimen was released.

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.